Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/28/1991 | WO1991017773A2 New protein-polycation conjugates |
11/28/1991 | WO1991017760A1 Composition of and treatment with biologically active peptides having d-amino acid residues |
11/28/1991 | WO1991017755A1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
11/28/1991 | WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
11/28/1991 | DE4016994A1 New anhydro-statin-phosphono:pyrrolidine(s) and -piperidine(s) - useful as antiviral cpds. in human and animal medicine, active against e.g. HIV |
11/28/1991 | CA2082631A1 Antisense inhibitors of the human immunodeficiency virus |
11/27/1991 | EP0458535A2 Therapeutic product for the treatment of cystic fibrosis |
11/27/1991 | EP0458363A1 Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines |
11/27/1991 | EP0458259A2 Novel antibiotic and process for preparing the same |
11/27/1991 | CN1056428A Actinobacillus pleuropneumoniae subunit vaccine |
11/27/1991 | CN1056421A Protection from shock subsequent to injury by double-stranded rnas |
11/27/1991 | CA2043216A1 Use of substituted .beta.-hydroxyethylamines as potent inhibitors of the exoenzymes of fungi |
11/27/1991 | CA2043143A1 Retrovirally active new anhydrostatin phosphonopyrrolidines and piperidines |
11/26/1991 | US5068349 Mitomycin derivatives |
11/26/1991 | US5068320 2-amino-6-(cyclopropylamino)purine-9-β-D-2',3'-dideoxyribofuranoside and its pharmaceutically acceptable salts |
11/26/1991 | US5068314 Lipopolysaccharide-binding polypeptide |
11/26/1991 | US5068232 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
11/26/1991 | US5068064 N-substituted lauramides, their preparation and compositions in which they are present |
11/26/1991 | CA1292472C Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
11/26/1991 | CA1292468C Nucleosides of 5-monofluoromethyluracil and 5- difluoromethyluracil |
11/25/1991 | CA2043132A1 Therapeutic product |
11/25/1991 | CA2042931A1 Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines |
11/21/1991 | EP0457381A2 Delta 2-cephem sulphones |
11/21/1991 | EP0457326A1 Antiviral agents |
11/21/1991 | EP0456843A1 Bornyl and isobornyl carboxylic esters of condensed tetrahydroquinoxalines as antiviral agents |
11/21/1991 | EP0456719A1 Anti-idiotype antibodies reactive with shared idiotopes expressed by human lymphomas and autoantibodies |
11/20/1991 | CN1014789B Process for preparing replacable bridged heavy nitrogen bicycloalkyl carbostyril carboxylic acid |
11/19/1991 | US5066805 Catalytic hydrogenation of 2-amino-6-chloropurine |
11/19/1991 | US5066802 Process for preparing pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues |
11/19/1991 | US5066800 Qunoline intermediates useful therein for synthesizing antibacterial compounds |
11/19/1991 | US5066646 Antifungal Agents |
11/19/1991 | US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
11/18/1991 | CA2042795A1 Antiviral agents |
11/17/1991 | WO1991017764A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
11/17/1991 | CA2042458A1 Oligophosphates with an antiviral action |
11/15/1991 | CA2042468A1 Compositions of and treatment with biologically active peptides having d-amino acid residues |
11/14/1991 | WO1991017159A1 1,3-oxathiolane nucleoside analogues |
11/14/1991 | WO1991016918A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
11/14/1991 | CA2337748A1 1,3-oxathiolane nucleoside analogues |
11/13/1991 | EP0456468A2 Complex of dideoxynucleoside and phosphonoformic acid |
11/13/1991 | EP0456418A2 Treatment of clostridium difficile diarrhoea and pseudomembranous colitis |
11/13/1991 | EP0456185A2 Renin inhibitors |
11/13/1991 | EP0456149A1 9-Substituted compounds of 3 alpha, 11 alpha-Epoxy-3,4,5, 5a alpha,6,7,8,8a,9,11,11a-undecahydro-3 beta, 6 alpha, 9-trimethylfurano[3,4-j][1,2]-benzodioxepin, processes for their preparation and their use as antiprotozoal and antiviral agents |
11/13/1991 | EP0455719A1 SYNERGISTIC COMPOSITION CONTAINING A MAGAININ PEPTIDE AND A PGLa PEPTIDE |
11/13/1991 | EP0414806A4 High ratio active agent:lipid complex |
11/13/1991 | CN1056104A Process for preparing nojirimycin derivatives |
11/13/1991 | CN1014710B Process for 6-beta (substrated)-shydroxymethyl-penicillanic acid and its derivatives |
11/12/1991 | WO1991018014A1 Anti-viral therapy |
11/12/1991 | US5064961 Process for preparing an optically active cyclobutane nucleoside |
11/12/1991 | US5064849 Heterocyclic derivatives useful as radiosensitizing agents and antiviral agents |
11/12/1991 | US5064811 De-mannosyl teicoplanin derivatives |
11/12/1991 | US5064649 Cephalosporin derivatives |
11/12/1991 | US5064647 Culture, poultry |
11/12/1991 | US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines |
11/12/1991 | CA2041825A1 Renin inhibitors |
11/12/1991 | CA1291993C 1-vinyl isoquinoline compounds |
11/11/1991 | CA2042242A1 Complex of dideoxynucleoside and phosphonoformic acid |
11/06/1991 | EP0455052A1 5-(1,2,4-Triazol-l-ylmethyl)-isoxazoline |
11/06/1991 | EP0454813A1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
11/06/1991 | EP0454781A1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof |
11/06/1991 | EP0454767A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
11/06/1991 | EP0309477B1 Ecteinascidins 729, 743, 745, 759a, 759b and 770 |
11/06/1991 | EP0192713B1 Xenocoumacins |
11/06/1991 | CN1055874A Aqueous ophthalmic solutions and method for preserving same |
11/05/1991 | WO1991017246A1 Modulation of gene expression through interference with rna secondary structure |
11/05/1991 | WO1991017170A1 Multimeric gelsolin fusion constructs |
11/05/1991 | WO1991016898A1 Anti-fungal bile acid derivatives |
11/05/1991 | US5063064 Lithium fluoride |
11/05/1991 | CA2081468A1 Anti-fungal bile acid derivatives |
11/05/1991 | CA2063593A1 Multimeric gelsolin fusion constructs |
11/05/1991 | CA1291765C Antimicrobial agents and process for their manufacture |
11/05/1991 | CA1291748C .beta.-LACTAM ANTIBIOTICS |
11/03/1991 | WO1991016894A1 Quinolizinone type compounds |
11/02/1991 | WO1991017266A1 Identification of novel drugs and reagents |
11/02/1991 | CA2081984A1 Identification of novel oligonucleotide drugs and reagents using combinational vector libraries |
10/31/1991 | WO1991016902A1 Inhibition of influenza virus replication by oligonucleotides |
10/31/1991 | WO1991016327A1 Antimicrobial quinolonyl lactams |
10/31/1991 | WO1991016324A1 Novel cc-1065 analogs |
10/31/1991 | WO1991016310A1 Antimicrobial quinolone thioureas |
10/31/1991 | WO1991016073A1 Oral vaccine comprising antigen surface-associated with red blood cells |
10/31/1991 | WO1991016066A1 Composition and treatment with biologically active peptides and toxic cations |
10/31/1991 | WO1991016054A1 Azo-derivatives, pharmaceutical preparations containing them, and their use against aids |
10/31/1991 | WO1991016024A1 Cationic lipids for intracellular delivery of biologically active molecules |
10/31/1991 | DE4037604A1 Use of anti-TNF antibodies to treat ischaemia and its sequelae - esp. to increase survival rate after myocardial infarct and transplants |
10/31/1991 | CA2081777A1 Inhibition of influenza virus replication by oligonucleotides |
10/31/1991 | CA2080477A1 Oral vaccine comprising antigen surface-associated with red blood cells |
10/31/1991 | CA2078444A1 Antimicrobial quinolonyl lactams |
10/31/1991 | CA2077435A1 Novel antimicrobial quinolone thioureas |
10/31/1991 | CA2062715A1 Saccharide compositions, methods and apparatus for their synthesis |
10/30/1991 | EP0454580A2 Novel nojirimycin derivatives |
10/30/1991 | EP0454494A2 Calicheamicinone, derivatives and analogs thereof and methods of making the same |
10/30/1991 | EP0454469A1 Carboxylic acid derivatives |
10/30/1991 | EP0454441A1 Antimicrobial compositions and process for preparing the same |
10/30/1991 | EP0454427A1 Antiretroviral bases |
10/30/1991 | EP0454060A1 3-(Mercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, processes for their preparation, and pharmaceutical compositions |
10/30/1991 | EP0453952A2 A process for synthesizing cephalosporin compounds |
10/30/1991 | EP0453924A1 A process for synthesizing cephalosporin compounds |
10/30/1991 | EP0453898A2 Use of TNF-specific antibodies as a drug for treatment of ischemias and of their consequences |
10/30/1991 | EP0453841A2 Process for the preparation of esters of 1-alcoxyhexatriene-2-carboxylic acid |
10/30/1991 | EP0453692A1 Novel nojirimycin derivatives |